Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Brent L. Kane"'
1
Akademický článek
High Dose 'HDR-Like' Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial
Autor: Donald B. Fuller, Tami Crabtree, Brent L. Kane, Clinton A. Medbery, Robert Pfeffer, James R. Gray, Anuj Peddada, Trevor J. Royce, Ronald C. Chen
Publikováno v: Frontiers in Oncology, Vol 12 (2022)
Purpose/Objective(s)Although ample intermediate-term prostate stereotactic body radiotherapy (SBRT) outcomes have been reported, 10-year results remain relatively sparse.Materials/MethodsEighteen institutions enrolled 259 low- and intermediate-risk p
Externí odkaz: https://doaj.org/article/8e44a84c0de74467b6ce47a093c00fd0
Zobrazit plný text záznamu
2
Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial
Autor: Kyle Wang, Brent L. Kane, Anuj V. Peddada, Donald B. Fuller, Ronald C. Chen, Clinton A. Medbery, K. Underhill, J. R. Gray
Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 102:1430-1437
Purpose Stereotactic body radiation therapy (SBRT) is an emerging option for localized prostate cancer. However, there are no standard dosimetric guidelines, and normal tissue tolerances for extreme hypofractionation are not well defined. We analyzed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5510d89a250be3340243264fa7798f0a
https://doi.org/10.1016/j.ijrobp.2018.07.191
Zobrazit plný text záznamu
3
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes
Autor: Kelly Underhill, Donald B. Fuller, Brent L. Kane, Clinton A. Medbery, Ronald C. Chen, Tami Crabtree, Anuj V. Peddada, J. R. Gray, Aaron D. Falchook
Publikováno v: European Urology Oncology. 1:540-547
Background Stereotactic body radiation therapy is an emerging treatment for prostate cancer (PC), with potential biological and oncologic advantages. A well-established radiation dosing schedule (38Gy in 4 fractions) has shown excellent long-term eff
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df0dac258d5f8cd32c822da60cd56e24
https://doi.org/10.1016/j.euo.2018.06.013
Zobrazit plný text záznamu
7
5-year outcomes from a prospective multi-institutional trial of heterogeneous dosing stereotactic body radiotherapy (SBRT) for low- and intermediate-risk prostate cancer
Autor: Kelly Underhill, J. R. Gray, Ronald C. Chen, Donald B. Fuller, Anuj V. Peddada, Brent L. Kane, Clinton A. Medbery
Publikováno v: Journal of Clinical Oncology. 35:35-35
35 Background: SBRT is an emerging treatment for prostate cancer, but long-term reporting remains sparse. We present a prospective Phase II trial with 90% treated in community facilities. Methods: 14 institutions enrolled 259 patients - 112 low-risk;
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10c0559bc6c507b1e9b652eb60df0895
https://doi.org/10.1200/jco.2017.35.6_suppl.35
Zobrazit plný text záznamu
8
Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315
Autor: Lawrence Berk, Lisa A. Kachnic, Marvin Rotman, Lisa J. Chin, Seth A. Rosenthal, David Donath, Jaffer A. Ajani, Jennifer L. James, Brent L. Kane, Clement K. Gwede, Babu Zachariah
Publikováno v: Journal of the National Cancer Institute. 102(8)
Background In anorectal cancer patients, an acute side effect of chemoradiotherapy is gastrointestinal toxicity, which often impedes treatment delivery. Based on previous trials, octreotide acetate is widely recommended for the control of chemotherap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa31c3568f40d9ff133dcb6e340d4568
https://pubmed.ncbi.nlm.nih.gov/20339140
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje